DeepXray vs AZmed

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

DeepXray

by Alpha Intelligence Manifolds

AZmed

by AZmed

AI Verdict

DeepXray focuses on detecting and monitoring chronic bone diseases like osteoarthritis and osteoporosis, providing automated measurements and disease assessment. AZmed's Rayvolve, on the other hand, specializes in the rapid detection of various types of fractures on X-ray images, aiming to improve diagnostic accuracy and efficiency in emergency and orthopedic settings. While both utilize AI for X-ray analysis in orthopedics, their primary diagnostic targets differ, making them complementary rather than direct competitors.

Choose DeepXray if…

Choose DeepXray if your primary focus is the comprehensive detection and monitoring of chronic bone diseases like osteoarthritis and osteoporosis. This tool excels at automated measurements of joint space width, assessment of osteoarthritis signs, and precise bone mineral density (BMD) estimation from X-rays, offering detailed progression monitoring and interactive reports for long-term patient management.

View DeepXray →

Choose AZmed if…

Choose AZmed's Rayvolve if your priority is rapid and accurate fracture detection across various anatomical regions, including pediatric fractures. This AI-powered software seamlessly integrates into existing PACS/RIS workflows, significantly reducing false negatives and turnaround times in emergency departments and orthopedic clinics where quick diagnosis is critical.

View AZmed →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	DeepXray	AZmed
Pricing	Subscription-based	Contact for pricing
Deployment	SaaS, on-premise, hybrid	Cloud-based, On-premise
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Both DeepXray and AZmed Rayvolve emphasize seamless integration into existing clinical workflows (PACS/RIS) and aim to reduce clicks and interpretation time, suggesting a focus on user experience. DeepXray offers an interactive web-based report, while Rayvolve integrates directly into the PACS environment as a DICOM Secondary Capture. Without direct user feedback or comparative studies on their interfaces, it's difficult to definitively declare a winner in usability.

Clinical Value

AZmed

AZmed Rayvolve has a broader scope, offering AI-powered fracture detection across multiple anatomical regions for both adult and pediatric populations, as well as modules for chest abnormalities, osteo-articular measurements, and bone age assessment. DeepXray focuses on osteoarthritis and osteoporosis detection and monitoring, primarily for knees and hips/spine. While both are FDA-cleared and clinically validated, Rayvolve's wider range of applications and documented reduction in false negatives and interpretation time suggest a slightly higher clinical value for a broader set of use cases.

Pricing & Value

Tie

Both companies utilize a subscription-based pricing model and require direct contact for detailed pricing information, indicating a lack of public pricing transparency. Without specific pricing details or comprehensive value-based outcome data for both tools, it is not possible to determine which offers better pricing or overall value.

Enterprise Readiness

AZmed

AZmed Rayvolve demonstrates strong enterprise readiness with deployments in over 2,500 healthcare centers across 57+ countries, supporting multiple languages (English, French), and offering cloud-based and on-premise deployment options. DeepXray also offers SaaS, on-premise, and hybrid deployments and is HIPAA compliant with FDA clearance, but its global deployment scale and language support are not as extensively detailed. Rayvolve's emphasis on seamless PACS/RIS integration and federated learning for data privacy further highlights its enterprise capabilities.

Innovation

AZmed

AZmed Rayvolve showcases innovation through its comprehensive AI suite covering a wide range of pathologies (fractures, chest abnormalities, bone age, measurements) and its use of federated learning for model improvement while maintaining data privacy. DeepXray focuses on automated measurements and progression monitoring for osteoarthritis and osteoporosis, which is valuable but appears to be a more specialized application compared to Rayvolve's broader AI platform and continuous global learning approach.

Support & Docs

Tie

Both companies are established in the healthcare AI space and have FDA clearances, implying a level of regulatory documentation and support. However, neither company's publicly available information or web search results provide specific details about their customer support channels, service level agreements, or the extent and accessibility of their documentation. Therefore, it is not possible to pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	DeepXray	AZmed
Company	Alpha Intelligence Manifolds	AZmed
Description	AI-powered software for analyzing X-rays to detect and monitor osteoarthritis and osteoporosis, providing automated measurements, disease assessment, and interactive reports for medical professionals.	AI-powered software by AZmed that assists physicians in detecting fractures on X-ray images to improve diagnostic accuracy and efficiency.
Categories	Clinical Decision Support & Reference, Radiology & Imaging AI	Clinical Decision Support & Reference, Radiology & Imaging AI
Specialties	Orthopedics, Radiology, Rheumatology	Emergency Medicine, Orthopedics, Radiology
Key Features	AI-assisted diagnosis system for knee X-rays (osteoarthritis), Automated measurement of joint space width, Assessment of osteoarthritis signs (sclerosis, joint space narrowing, osteophytes), Grading based on OARSI criteria, Interactive report generation for clinician review and editing, AI-assisted diagnosis system for osteoporosis using X-rays (DeepXray Coxa/Spina), Automated progression monitoring for chronic bone diseases, Bone Mineral Density (BMD) estimation (DeepXray Coxa/Spina)	AI-powered fracture detection, X-ray image analysis, Integration with existing PACS, CE-marked medical device, Supports multiple anatomical regions
Languages	English, Japanese	English, French

Videos

Demos, reviews, and walkthroughs featuring DeepXray and AZmed.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing radiology workflows and EHR systems?

DeepXray provides interactive reports for clinician review and editing, and its output is rendered as a summary report viewable on a web browser. Rayvolve by AZmed is designed for seamless integration into existing PACS, RIS, or EMR environments, directly connecting without requiring additional clicks from physicians. Rayvolve can return inference results to PACS as a DICOM Secondary Capture, appearing natively, and allows for RIS-integrated structured report pre-fill into partner systems.

What is the accuracy and sensitivity of each tool for its specific diagnostic focus?

DeepXray Coxa, for osteoporosis detection, claims high accuracy that rivals DXA and complies with international standards. For osteoarthritis, DeepXray Genu provides automated measurements and assessments based on OARSI criteria. Rayvolve has demonstrated high accuracy in fracture detection; a study showed it increased physician accuracy by 5.6%, improved sensitivity from 86.5% to 95.5%, and boosted specificity from 82.6% to 83.1% in adult fracture detection. For pediatric fractures, Rayvolve showed a 96% sensitivity rate and 86% specificity in a study involving 3,000 patients.

What is the learning curve for physicians using these AI tools?

Rayvolve is designed to be easy to use, integrating deep learning technologies directly into doctors' workflow without requiring changes in their work habits. It aims to augment the work of the radiologist, not replace them, and results are displayed within the PACS interface to keep radiologists focused on interpretation. DeepXray is intended for use by trained professionals including radiologists, orthopedists, physicians, and medical technicians.

What kind of support and customer references are available for each tool?

AZmed's Rayvolve is used in over 2,500 healthcare centers in 55+ countries, analyzing millions of X-rays yearly. They have a strong scientific backing with more than 30 clinical studies and 10+ publications. DeepXray is T-FDA approved and aims to upgrade X-ray modalities in clinics/hospitals to smart X-ray modalities.

What audit-trail features do these tools offer to ensure accountability and transparency?

Rayvolve's integration allows for RIS-integrated structured report pre-fill, which can standardize reports and reduce variability across teams and shifts. AZmed emphasizes that a radiology AI tool built to meet high audit standards provides a greater level of auditability, with more logged events and encrypted data flows. DeepXray generates interactive reports for clinician review and editing, which could contribute to an audit trail.

How do these tools handle multi-site rollouts and data governance across different locations?

Rayvolve's interoperability through standards-based messaging enables sites to expand to new locations without losing the source of truth in PACS/RIS. AZmed, headquartered in Paris, operates natively under GDPR, which suggests a robust approach to data privacy and governance that could facilitate multi-site rollouts, especially in regions with similar regulations. DeepXray offers SaaS, on-premise, and hybrid deployment options, which can provide flexibility for multi-site rollouts depending on an institution's IT infrastructure and data governance requirements.

In what clinical contexts would a physician choose DeepXray over AZmed, or vice-versa?

A physician would choose DeepXray if their primary focus is on the detection and monitoring of osteoarthritis and osteoporosis, as it offers automated measurements, disease assessment, and progression monitoring for these specific chronic bone diseases. Conversely, a physician would choose AZmed's Rayvolve if their main need is AI-powered fracture detection across multiple anatomical regions, including adult and pediatric populations, and for improving diagnostic accuracy and efficiency in emergency and orthopedic settings.